Literature DB >> 19710254

Monoclonal antibodies to the West Nile virus NS5 protein map to linear and conformational epitopes in the methyltransferase and polymerase domains.

Roy A Hall1, Si En Tan1, Barbara Selisko2, Rachael Slade1, Jody Hobson-Peters1, Bruno Canard2, Megan Hughes1, Jason Y Leung1, Ezequiel Balmori-Melian1, Sonja Hall-Mendelin1, Kim B Pham1, David C Clark1, Natalie A Prow1, Alexander A Khromykh1.   

Abstract

The West Nile virus (WNV) NS5 protein contains a methyltransferase (MTase) domain involved in RNA capping and an RNA-dependent RNA polymerase (RdRp) domain essential for virus replication. Crystal structures of individual WNV MTase and RdRp domains have been solved; however, the structure of full-length NS5 has not been determined. To gain more insight into the structure of NS5 and interactions between the MTase and RdRp domains, we generated a panel of seven monoclonal antibodies (mAbs) to the NS5 protein of WNV (Kunjin strain) and mapped their binding sites using a series of truncated NS5 proteins and synthetic peptides. Binding sites of four mAbs (5D4, 4B6, 5C11 and 6A10) were mapped to residues 354-389 in the fingers subdomain of the RdRp. This is consistent with the ability of these mAbs to inhibit RdRp activity in vitro and suggests that this region represents a potential target for RdRp inhibitors. Using a series of synthetic peptides, we also identified a linear epitope (bound by mAb 5H1) that mapped to a 13 aa stretch surrounding residues 47 and 49 in the MTase domain, a region predicted to interact with the palm subdomain of the RdRp. The failure of one mAb (7G6) to bind both N- and C-terminally truncated NS5 recombinants indicates that the antibody recognizes a conformational epitope that requires the presence of residues in both the MTase and RdRp domains. These data support a structural model of the full-length NS5 molecule that predicts a physical interaction between the MTase and the RdRp domains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710254     DOI: 10.1099/vir.0.013805-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme.

Authors:  Hillary J Stahla-Beek; Daniel G April; Bejan J Saeedi; Amanda M Hannah; Susan M Keenan; Brian J Geiss
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

2.  A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity.

Authors:  Judith Edmonds; Erinke van Grinsven; Natalie Prow; Angela Bosco-Lauth; Aaron C Brault; Richard A Bowen; Roy A Hall; Alexander A Khromykh
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

3.  Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein.

Authors:  Martha Sedegah; Yohan Kim; Bjoern Peters; Shannon McGrath; Harini Ganeshan; Jennylynn Lejano; Esteban Abot; Glenna Banania; Maria Belmonte; Renato Sayo; Fouzia Farooq; Denise L Doolan; David Regis; Cindy Tamminga; Ilin Chuang; Joseph T Bruder; C Richter King; Christian F Ockenhouse; Bart Faber; Edmond Remarque; Michael R Hollingdale; Thomas L Richie; Alessandro Sette
Journal:  Malar J       Date:  2010-08-24       Impact factor: 2.979

4.  The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling.

Authors:  Maudry Laurent-Rolle; Elena F Boer; Kirk J Lubick; James B Wolfinbarger; Aaron B Carmody; Barry Rockx; Wenjun Liu; Joseph Ashour; W Lesley Shupert; Michael R Holbrook; Alan D Barrett; Peter W Mason; Marshall E Bloom; Adolfo García-Sastre; Alexander A Khromykh; Sonja M Best
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

5.  Characterization of virulent West Nile virus Kunjin strain, Australia, 2011.

Authors:  Melinda J Frost; Jing Zhang; Judith H Edmonds; Natalie A Prow; Xingnian Gu; Rodney Davis; Christine Hornitzky; Kathleen E Arzey; Deborah Finlaison; Paul Hick; Andrew Read; Jody Hobson-Peters; Fiona J May; Stephen L Doggett; John Haniotis; Richard C Russell; Roy A Hall; Alexander A Khromykh; Peter D Kirkland
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

6.  Japanese encephalitis virus nonstructural protein NS5 interacts with mitochondrial trifunctional protein and impairs fatty acid β-oxidation.

Authors:  Yu-Ting Kao; Bi-Lan Chang; Jian-Jong Liang; Hang-Jen Tsai; Yi-Ling Lee; Ren-Jye Lin; Yi-Ling Lin
Journal:  PLoS Pathog       Date:  2015-03-27       Impact factor: 6.823

7.  Viral RNA intermediates as targets for detection and discovery of novel and emerging mosquito-borne viruses.

Authors:  Caitlin A O'Brien; Jody Hobson-Peters; Alice Wei Yee Yam; Agathe M G Colmant; Breeanna J McLean; Natalie A Prow; Daniel Watterson; Sonja Hall-Mendelin; David Warrilow; Mah-Lee Ng; Alexander A Khromykh; Roy A Hall
Journal:  PLoS Negl Trop Dis       Date:  2015-03-23

8.  The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody Recognition.

Authors:  Lucas Y H Goh; Jody Hobson-Peters; Natalie A Prow; Kelly Baker; Thisun B H Piyasena; Carmel T Taylor; Ashok Rana; Marcus L Hastie; Jeff J Gorman; Roy A Hall
Journal:  Viruses       Date:  2015-06-08       Impact factor: 5.048

9.  Cullin4 Is Pro-Viral during West Nile Virus Infection of Culex Mosquitoes.

Authors:  Prasad N Paradkar; Jean-Bernard Duchemin; Julio Rodriguez-Andres; Lee Trinidad; Peter J Walker
Journal:  PLoS Pathog       Date:  2015-09-01       Impact factor: 6.823

Review 10.  The changing epidemiology of Kunjin virus in Australia.

Authors:  Natalie A Prow
Journal:  Int J Environ Res Public Health       Date:  2013-11-25       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.